• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潜在的抗动脉粥样硬化剂。4. 西他本的[(官能化烷基)氨基]苯甲酸类似物。

Potential antiatherosclerotic agents. 4. [(Functionalized-alkyl)amino]benzoic acid analogues of cetaben.

作者信息

DeVries V G, Largis E E, Miner T G, Shepherd R G, Upeslacis J

出版信息

J Med Chem. 1983 Oct;26(10):1411-21. doi: 10.1021/jm00364a011.

DOI:10.1021/jm00364a011
PMID:6604818
Abstract

The synthesis of a series of analogues in which the alkyl group of cetaben is substituted with various functional groups or replaced entirely by a functionalized alkanoyl moiety is described. Also reported are the syntheses of branched-chain (alkylamino)benzoic acids in which branching is specifically localized at the terminus of the alkyl chain. Structure-activity relationships of these compounds, both as hypolipidemic agents and as inhibitors of the enzyme fatty acyl-CoA:cholesterol acyltransferase (ACAT), are discussed. Certain compounds were specifically synthesized to test the hypothesis that groups located near the terminus of the alkyl chain of cetaben might retard metabolic degradation of the molecule and, thus, enhance biological activity. Some of these (48-50) were found to be the most active analogues synthesized.

摘要

本文描述了一系列类似物的合成,其中西他苯的烷基被各种官能团取代或完全被功能化的烷酰基部分取代。还报道了支链(烷基氨基)苯甲酸的合成,其中支链特定地位于烷基链的末端。讨论了这些化合物作为降血脂剂和酶脂肪酰基辅酶A:胆固醇酰基转移酶(ACAT)抑制剂的构效关系。专门合成了某些化合物以检验这样的假设,即位于西他苯烷基链末端附近的基团可能会延缓分子的代谢降解,从而增强生物活性。其中一些化合物(48 - 50)被发现是合成的最具活性的类似物。

相似文献

1
Potential antiatherosclerotic agents. 4. [(Functionalized-alkyl)amino]benzoic acid analogues of cetaben.潜在的抗动脉粥样硬化剂。4. 西他本的[(官能化烷基)氨基]苯甲酸类似物。
J Med Chem. 1983 Oct;26(10):1411-21. doi: 10.1021/jm00364a011.
2
Potential antiatherosclerotic agents. 3. Substituted benzoic and non benzoic acid analogues of cetaben.潜在的抗动脉粥样硬化药物。3. 西他本的取代苯甲酸和非苯甲酸类似物。
J Med Chem. 1983 Oct;26(10):1393-411. doi: 10.1021/jm00364a010.
3
Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino) benzoic acid analogues of cetaben.潜在的抗动脉粥样硬化剂。2. 西他本的(芳烷基氨基)和(烷基氨基)苯甲酸类似物。
J Med Chem. 1983 Oct;26(10):1378-93. doi: 10.1021/jm00364a009.
4
Cetaben sodium, an antiatherosclerotic agent.西他苯钠,一种抗动脉粥样硬化药物。
J Pharm Sci. 1979 Jul;68(7):936-7. doi: 10.1002/jps.2600680749.
5
Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.二氢蝶酸合酶抑制剂:6-[[3-(芳氧基)丙基]氨基]-5-亚硝基异胞嘧啶侧链芳香环上的取代基效应以及桥连的5-亚硝基异胞嘧啶-对氨基苯甲酸类似物的合成与抑制活性
J Med Chem. 1986 May;29(5):665-70. doi: 10.1021/jm00155a014.
6
Probiotics: antistaphylococcal activity of 4-aminocyclohexanecarboxylic acid, aminobenzoic acid, and their derivatives and structure-activity relationships.益生菌:4-氨基环己烷羧酸、氨基苯甲酸及其衍生物的抗葡萄球菌活性以及构效关系
J Pharm Sci. 1977 Jun;66(6):844-8. doi: 10.1002/jps.2600660628.
7
Antiatherogenic activity of cetaben sodium, sodium p-(hexadecylamino) benzoate, in the aortae of hypercholesteremic rabbits subjected to aortic endothelial cell desquamation.对羟基十六烷基氨基苯甲酸钠(西他苯钠)在主动脉内皮细胞剥脱的高胆固醇血症兔主动脉中的抗动脉粥样硬化活性。
Artery. 1982;11(3):192-206.
8
Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.酰基辅酶A:胆固醇O-酰基转移酶(ACAT)抑制剂。2. 2-(1,3-二氧杂环己烷-2-基)-4,5-二苯基-1H-咪唑作为ACAT的强效抑制剂。
J Med Chem. 1996 Mar 29;39(7):1423-32. doi: 10.1021/jm9505876.
9
Structure-activity relationship of a series of phenylureas linked to 4-phenylimidazole. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity. 2.一系列与4-苯基咪唑相连的苯基脲的构效关系。具有抗动脉粥样硬化活性的新型强效酰基辅酶A:胆固醇O-酰基转移酶抑制剂。2.
J Med Chem. 1993 May 28;36(11):1641-53. doi: 10.1021/jm00063a014.
10
The hypolipidemic compound cetaben induces changes in Golgi morphology and vesicle movement.降血脂化合物西他本可诱导高尔基体形态和囊泡运动发生变化。
Histochem Cell Biol. 2004 Aug;122(2):95-109. doi: 10.1007/s00418-004-0689-6. Epub 2004 Jul 28.